Boyan Vesselinov Litchev - 31 Jan 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Medical Officer
Signature
/s/ Boyan Litchev
Issuer symbol
INDP
Transactions as of
31 Jan 2022
Net transactions value
+$2,520
Form type
4
Filing time
19 Dec 2022, 20:06:32 UTC
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INDP Common Stock Purchase $465 +100 $4.65 100 31 Jan 2022 Direct
transaction INDP Common Stock Purchase $205 +50 +50% $4.09 150 02 Mar 2022 Direct
transaction INDP Common Stock Purchase $915 +500 +333% $1.83 650 22 Nov 2022 Direct
transaction INDP Common Stock Purchase $935 +500 +77% $1.87 1,150 01 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.